Margaret Chan nominated to be WHO Director General

13 November 2006

Margaret Chan of China has been nominated by the Executive Board of the World Health Organization for the post of Director General, following the sudden death of Lee Jong-wook in May (Marketletters passim). Dr Chan has previously served as Assistant DG, responsible for communicable diseases, where "she has shown a capability to focus on obtaining concrete results and is willing to work with partners who can help achieve them," said International Federation of Pharmaceutical Manufacturers and Associations director general Harvey Bale, welcoming the nomination, which awaited confirmation as the Marketletter went to press.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight